Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1

Mattia Mori, Davide Deodato, Mohan Kasula, Davide M. Ferraris, Adriana Sanna, Alessandro De Logu, Menico Rizzi, Maurizio Botta

Research output: Contribution to journalArticlepeer-review

Abstract

Sixteen 3-(carboxymethyl)rhodanines, and twelve aminothiazoles as rhodanine-mimetics were designed, synthesized and tested as inhibitors of the Zmp1 enzyme from Mycobacterium tuberculosis (Mtb). Almost all rhodanines (5a–d, 5f–n, and 7a–b) exhibited Zmp1 inhibition with IC50 values in the range 1.3–43.9 µM, whereas only aminothiazoles 12b and 12d proved active with IC50 values of 41.3 and 35.7 µM, respectively. Structure-activity relationships (SAR) were coupled with molecular modeling studies to highlight structural determinants for Zmp1 inhibition. Moreover, rhodanines 5a and 5c induced 23.4 and 53.8% of Mtb growth inhibition in THP-1 infected cells, respectively, at the non-toxic concentration of 10 µg/ml. This work represents a step forward in targeting Zmp1 by small molecules.

Original languageEnglish
Pages (from-to)637-641
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume28
Issue number4
DOIs
Publication statusPublished - 15 Feb 2018

Keywords

  • Aminothiazoles
  • Metalloproteases
  • Rhodanines
  • Tuberculosis
  • Zmp1

Fingerprint

Dive into the research topics of 'Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1'. Together they form a unique fingerprint.

Cite this